CRYOPORT, INC. Net Income
CRYOPORT, INC. (CYRX) reported Net Income of -$8.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-06
- CRYOPORT, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$8.26M, a 107.58% decline year-over-year.
- CRYOPORT, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$10.54M.
- CRYOPORT, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$11.64M.
- CRYOPORT, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$6.94M, a 962.48% decline year-over-year.
- CRYOPORT, INC. net income (loss) attributable to parent for fiscal 2020 was -$32.69M.
- CRYOPORT, INC. net income (loss) attributable to parent for fiscal 2019 was -$18.33M.
- CRYOPORT, INC. net income (loss) attributable to parent for fiscal 2018 was -$9.56M.
- CRYOPORT, INC. net income (loss) attributable to parent for fiscal 2017 was -$7.90M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$8.26M 10-Q · filed 2026-08-06 | -$18.80M 10-Q · filed 2026-08-06 | -$30.44M derived: sum of 3 quarters · filed 2026-08-06 | -$37.39M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$10.54M 10-Q · filed 2026-05-05 | -$22.19M derived: sum of 2 quarters · filed 2026-05-05 | -$29.13M derived: sum of 3 quarters · filed 2026-05-05 | $79.74M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$11.64M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$18.59M derived: sum of 2 quarters · filed 2026-04-22 | $90.28M derived: sum of 3 quarters · filed 2026-08-06 | $78.30M DEF 14A · filed 2026-04-22 | $78.30M 10-K · filed 2026-03-05 | |||
| 2025-09-30 | -$6.94M 10-Q · filed 2025-11-06 | $101.93M derived: sum of 2 quarters · filed 2026-08-06 | $89.94M 10-Q · filed 2025-11-06 | $71.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $108.87M 10-Q · filed 2026-08-06 | $105.18M 10-Q · filed 2025-08-12 | $96.89M 10-Q · filed 2026-08-06 | $93.20M 10-Q · filed 2025-08-12 | $78.21M derived: sum of 3 quarters · filed 2026-08-06 | $79.01M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$11.98M 10-Q · filed 2026-05-05 | -$30.66M derived: sum of 2 quarters · filed 2026-05-05 | -$29.86M derived: sum of 3 quarters · filed 2026-05-05 | -$107.85M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$18.68M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$17.88M derived: sum of 2 quarters · filed 2026-04-22 | -$95.86M derived: sum of 3 quarters · filed 2026-04-22 | -$114.76M DEF 14A · filed 2026-04-22 | -$114.76M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | $805.00K 10-Q · filed 2025-11-06 | -$77.18M derived: sum of 2 quarters · filed 2025-11-06 | -$96.08M 10-Q · filed 2025-11-06 | -$158.47M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-06-30 | -$77.99M 10-Q · filed 2025-08-12 | -$96.88M 10-Q · filed 2025-08-12 | -$159.28M derived: sum of 3 quarters · filed 2026-04-22 | -$172.54M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-03-31 | -$18.89M 10-Q · filed 2025-05-08 | -$81.29M derived: sum of 2 quarters · filed 2026-04-22 | -$94.56M derived: sum of 3 quarters · filed 2026-04-22 | -$112.91M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2023-12-31 | -$62.39M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$75.66M derived: sum of 2 quarters · filed 2026-04-22 | -$94.02M derived: sum of 3 quarters · filed 2026-04-22 | -$99.59M DEF 14A · filed 2026-04-22 | -$99.59M 10-K · filed 2024-03-13 | |||
| 2023-09-30 | -$13.27M 10-Q · filed 2024-11-07 | -$31.62M derived: sum of 2 quarters · filed 2024-11-07 | -$37.20M 10-Q · filed 2024-11-07 | -$46.63M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2023-06-30 | -$18.36M 10-Q · filed 2024-08-08 | -$23.93M 10-Q · filed 2024-08-08 | -$33.36M derived: sum of 3 quarters · filed 2026-04-22 | -$38.68M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2023-03-31 | -$5.57M 10-Q · filed 2024-05-08 | -$15.01M derived: sum of 2 quarters · filed 2026-04-22 | -$20.32M derived: sum of 3 quarters · filed 2026-04-22 | -$29.50M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2022-12-31 | -$9.43M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$14.75M derived: sum of 2 quarters · filed 2026-04-22 | -$23.93M derived: sum of 3 quarters · filed 2026-04-22 | -$37.33M DEF 14A · filed 2026-04-22 | -$37.33M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$5.32M 10-Q · filed 2023-11-09 | -$14.49M derived: sum of 2 quarters · filed 2023-11-09 | -$27.90M 10-Q · filed 2023-11-09 | -$287.99M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2022-06-30 | -$9.18M 10-Q · filed 2023-08-09 | -$22.58M 10-Q · filed 2023-08-09 | -$282.67M derived: sum of 3 quarters · filed 2026-04-22 | -$289.19M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2022-03-31 | -$13.40M 10-Q · filed 2023-05-04 | -$273.49M derived: sum of 2 quarters · filed 2026-04-22 | -$280.02M derived: sum of 3 quarters · filed 2026-04-22 | -$285.41M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2021-12-31 | -$260.09M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$266.61M derived: sum of 2 quarters · filed 2026-04-22 | -$272.00M derived: sum of 3 quarters · filed 2026-04-22 | -$275.53M DEF 14A · filed 2026-04-22 | -$275.53M 10-K · filed 2022-02-28 | |||
| 2021-09-30 | -$6.53M 10-Q · filed 2022-11-04 | -$11.91M derived: sum of 2 quarters · filed 2022-11-04 | -$15.44M 10-Q · filed 2022-11-04 | -$26.97M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$5.39M 10-Q · filed 2022-08-04 | -$8.92M 10-Q · filed 2022-08-04 | -$20.45M derived: sum of 3 quarters · filed 2023-02-28 | -$31.86M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$3.53M 10-Q · filed 2022-05-05 | -$15.06M derived: sum of 2 quarters · filed 2023-02-28 | -$26.47M derived: sum of 3 quarters · filed 2023-02-28 | -$32.28M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$11.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$22.95M derived: sum of 2 quarters · filed 2023-02-28 | -$28.75M derived: sum of 3 quarters · filed 2023-02-28 | -$32.69M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | -$11.42M 10-Q · filed 2021-11-04 | -$11.42M 10-Q · filed 2020-11-06 | -$17.22M derived: sum of 2 quarters · filed 2021-11-04 | -$21.16M 10-Q · filed 2021-11-04 | -$21.16M 10-Q · filed 2020-11-06 | -$22.11M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | -$5.80M 10-Q · filed 2021-08-06 | -$5.80M 10-Q · filed 2020-08-10 | -$9.75M 10-Q · filed 2021-08-06 | -$9.75M 10-Q · filed 2020-08-10 | -$10.69M derived: sum of 3 quarters · filed 2021-08-06 | -$23.16M derived: sum of 4 quarters · filed 2021-08-06 | ||
| 2020-03-31 | -$3.94M 10-Q · filed 2021-05-06 | -$3.94M 10-Q · filed 2020-05-08 | -$4.89M derived: sum of 2 quarters · filed 2021-05-06 | -$17.36M derived: sum of 3 quarters · filed 2021-05-06 | -$19.89M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | -$948.00K 10-K · filed 2020-03-10 | -$13.42M derived: sum of 2 quarters · filed 2020-11-06 | -$15.95M derived: sum of 3 quarters · filed 2020-11-06 | -$18.33M 10-K · filed 2022-02-28 | -$18.33M 10-K · filed 2020-03-10 | |||
| 2019-09-30 | -$12.47M 10-Q · filed 2020-11-06 | -$15.00M derived: sum of 2 quarters · filed 2020-11-06 | -$17.38M 10-Q · filed 2020-11-06 | -$19.64M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$2.53M 10-Q · filed 2020-08-10 | -$4.92M 10-Q · filed 2020-08-10 | -$7.17M derived: sum of 3 quarters · filed 2020-08-10 | -$9.32M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$2.39M 10-Q · filed 2020-05-08 | -$4.64M derived: sum of 2 quarters · filed 2020-05-08 | -$6.79M derived: sum of 3 quarters · filed 2020-05-08 | -$9.26M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | -$2.26M 10-K · filed 2020-03-10 | -$4.40M derived: sum of 2 quarters · filed 2020-03-10 | -$6.87M derived: sum of 3 quarters · filed 2020-03-10 | -$9.56M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | -$2.14M 10-K · filed 2020-03-10 | -$2.14M 10-Q · filed 2018-11-08 | -$4.62M derived: sum of 2 quarters · filed 2020-03-10 | -$7.30M 10-Q · filed 2019-11-12 | -$9.57M derived: sum of 4 quarters · filed 2020-03-10 | |||
| 2018-06-30 | -$2.47M 10-K · filed 2020-03-10 | -$2.47M 10-Q · filed 2018-08-09 | -$5.15M 10-Q · filed 2019-08-09 | -$7.42M derived: sum of 3 quarters · filed 2020-03-10 | -$9.40M derived: sum of 4 quarters · filed 2020-03-10 | |||
| 2018-03-31 | -$2.68M 10-K · filed 2020-03-10 | -$2.68M 10-Q · filed 2018-05-03 | -$4.95M derived: sum of 2 quarters · filed 2020-03-10 | -$6.93M derived: sum of 3 quarters · filed 2020-03-10 | -$8.79M derived: sum of 4 quarters · filed 2020-03-10 | |||
| 2017-12-31 | -$2.27M 10-K · filed 2019-03-13 | -$4.25M derived: sum of 2 quarters · filed 2019-03-13 | -$6.11M derived: sum of 3 quarters · filed 2019-03-13 | -$7.90M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | -$1.98M 10-K · filed 2019-03-13 | -$1.98M 10-Q · filed 2017-11-02 | -$3.84M derived: sum of 2 quarters · filed 2019-03-13 | -$5.63M 10-Q · filed 2018-11-08 | -$9.91M derived: sum of 4 quarters · filed 2019-03-13 | |||
| 2017-06-30 | -$1.86M 10-K · filed 2019-03-13 | -$1.86M 10-Q · filed 2017-08-09 | -$3.65M 10-Q · filed 2018-08-09 | -$7.93M derived: sum of 3 quarters · filed 2019-03-13 | -$10.12M derived: sum of 4 quarters · filed 2019-03-13 | |||
| 2017-03-31 | -$1.79M 10-K · filed 2019-03-13 | -$1.79M 10-Q · filed 2017-05-04 | -$6.07M derived: sum of 2 quarters · filed 2019-03-13 | -$8.26M derived: sum of 3 quarters · filed 2019-03-13 | -$12.19M derived: sum of 4 quarters · filed 2019-03-13 | |||
| 2016-12-31 | -$4.28M 10-K · filed 2018-03-08 | -$6.47M derived: sum of 2 quarters · filed 2018-03-08 | -$10.40M 10-K · filed 2018-03-08 | -$13.11M 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | -$2.18M 10-K · filed 2018-03-08 | -$2.18M 10-Q · filed 2016-11-14 | -$6.12M 10-Q · filed 2016-11-14 | -$8.83M 10-Q · filed 2017-11-02 | -$9.12M derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2016-06-30 | -$3.94M 10-K · filed 2018-03-08 | -$3.93M 10-Q · filed 2016-08-15 | -$6.64M 10-Q · filed 2017-08-09 | -$6.93M derived: sum of 3 quarters · filed 2018-03-08 | -$9.60M derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2016-03-31 | $0.00 10-K · filed 2018-03-08 | -$3.00M derived: sum of 2 quarters · filed 2018-03-08 | -$5.67M derived: sum of 3 quarters · filed 2018-03-08 | -$9.82M 10-KT · filed 2017-03-13 | ||||
| 2015-12-31 | -$3.00M 10-KT · filed 2017-03-13 | -$2.76M 10-Q · filed 2016-02-11 | -$5.67M derived: sum of 2 quarters · filed 2017-03-13 | -$7.11M 10-KT · filed 2017-03-13 | -$15.06M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2015-09-30 | -$2.67M 10-KT · filed 2017-03-13 | -$2.43M 10-Q · filed 2015-11-16 | -$4.35M 10-Q · filed 2016-11-14 | -$12.06M derived: sum of 3 quarters · filed 2017-03-13 | -$13.46M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2015-06-30 | -$6.61M 10-KT · filed 2017-03-13 | -$1.92M 10-Q · filed 2015-08-06 | -$9.39M derived: sum of 2 quarters · filed 2017-03-13 | -$10.80M derived: sum of 3 quarters · filed 2017-03-13 | -$12.19M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2015-03-31 | -$2.79M 10-KT · filed 2017-03-13 | -$1.94M 10-K · filed 2015-05-19 | -$4.19M derived: sum of 2 quarters · filed 2017-03-13 | -$5.58M derived: sum of 3 quarters · filed 2017-03-13 | -$7.03M 10-K · filed 2016-06-28 | |||
| 2014-12-31 | -$1.41M 10-K · filed 2016-06-28 | -$1.41M 10-Q · filed 2015-02-05 | -$2.79M derived: sum of 2 quarters · filed 2016-06-28 | -$5.09M 10-Q · filed 2016-02-11 | -$6.53M derived: sum of 4 quarters · filed 2016-06-28 | |||
| 2014-09-30 | -$1.39M 10-K · filed 2016-06-28 | -$1.38M 10-Q · filed 2014-11-12 | -$3.68M 10-Q · filed 2015-11-16 | -$5.12M derived: sum of 3 quarters · filed 2016-06-28 | -$6.96M derived: sum of 4 quarters · filed 2016-06-28 | |||
| 2014-06-30 | -$2.30M 10-K · filed 2016-06-28 | -$2.30M 10-Q · filed 2014-07-31 | -$3.74M derived: sum of 2 quarters · filed 2016-06-28 | -$5.58M derived: sum of 3 quarters · filed 2016-06-28 | -$20.54M derived: sum of 4 quarters · filed 2016-06-28 | |||
| 2014-03-31 | -$1.44M 10-K · filed 2015-05-19 | -$3.28M derived: sum of 2 quarters · filed 2015-05-19 | -$18.24M derived: sum of 3 quarters · filed 2015-05-19 | -$19.57M 10-K · filed 2015-05-19 | ||||
| 2013-12-31 | -$1.84M 10-K · filed 2015-05-19 | -$1.84M 10-Q · filed 2014-02-13 | -$16.80M derived: sum of 2 quarters · filed 2015-05-19 | -$18.12M 10-Q · filed 2015-02-05 | -$19.84M derived: sum of 4 quarters · filed 2015-05-19 | |||
| 2013-09-30 | -$14.96M 10-K · filed 2015-05-19 | -$14.96M 10-Q · filed 2013-11-18 | -$16.28M 10-Q · filed 2014-11-12 | -$18.00M derived: sum of 3 quarters · filed 2015-05-19 | -$19.57M derived: sum of 4 quarters · filed 2015-05-19 | |||
| 2013-06-30 | -$1.32M 10-K · filed 2015-05-19 | -$1.32M 10-Q · filed 2013-08-14 | -$3.04M derived: sum of 2 quarters · filed 2015-05-19 | -$4.61M derived: sum of 3 quarters · filed 2015-05-19 | -$6.16M derived: sum of 4 quarters · filed 2015-05-19 | |||
| 2013-03-31 | -$1.72M 10-K · filed 2014-06-25 | -$1.72K 10-K · filed 2013-06-25 | -$3.28M derived: sum of 2 quarters · filed 2014-06-25 | -$4.83M derived: sum of 3 quarters · filed 2014-06-25 | -$6.38M 10-K · filed 2014-06-25 | |||
| 2012-12-31 | -$1.57M 10-K · filed 2014-06-25 | -$1.57M 10-Q · filed 2013-02-14 | -$3.12M derived: sum of 2 quarters · filed 2014-06-25 | -$4.67M 10-Q · filed 2014-02-13 | -$4.67M derived: sum of 4 quarters · filed 2014-06-25 | |||
| 2012-09-30 | -$1.55M 10-K · filed 2014-06-25 | -$1.55M 10-Q · filed 2012-11-09 | -$3.10M 10-Q · filed 2013-11-18 | -$3.10M derived: sum of 3 quarters · filed 2014-06-25 | -$3.10M derived: sum of 4 quarters · filed 2014-06-25 | |||
| 2012-06-30 | -$1.55M 10-K · filed 2014-06-25 | -$1.55M 10-Q · filed 2012-08-14 | -$1.55M derived: sum of 2 quarters · filed 2014-06-25 | -$1.55M derived: sum of 3 quarters · filed 2014-06-25 | -$1.55M derived: sum of 4 quarters · filed 2014-06-25 | |||
| 2012-03-31 | -$1.67K 10-K · filed 2013-06-25 | -$3.75K derived: sum of 2 quarters · filed 2013-06-25 | -$5.78K derived: sum of 3 quarters · filed 2013-06-25 | -$7.83M 10-K · filed 2013-06-25 | ||||
| 2011-12-31 | -$2.08K 10-K · filed 2013-06-25 | -$2.08M 10-Q · filed 2012-02-21 | -$4.11K derived: sum of 2 quarters · filed 2013-06-25 | -$6.16M 10-Q · filed 2013-02-14 | -$1.86M derived: sum of 4 quarters · filed 2013-06-25 | |||
| 2011-09-30 | -$2.03K 10-K · filed 2013-06-25 | -$2.03M 10-Q · filed 2011-11-14 | -$4.08M 10-Q · filed 2012-11-09 | -$1.86M derived: sum of 3 quarters · filed 2013-06-25 | -$3.32M derived: sum of 4 quarters · filed 2013-06-25 | |||
| 2011-06-30 | -$2.05K 10-K · filed 2013-06-25 | -$2.05M 10-Q · filed 2011-08-15 | -$1.86M derived: sum of 2 quarters · filed 2013-06-25 | -$3.32M derived: sum of 3 quarters · filed 2013-06-25 | -$4.83M derived: sum of 4 quarters · filed 2013-06-25 | |||
| 2011-03-31 | -$1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-27 | -$3.31M derived: sum of 2 quarters · filed 2012-06-27 | -$4.82M derived: sum of 3 quarters · filed 2012-06-27 | -$6.15M 10-K · filed 2012-06-27 | ||||
| 2010-12-31 | -$1.46M 10-Q · filed 2012-02-21 | -$2.97M derived: sum of 2 quarters · filed 2012-02-21 | -$4.30M 10-Q · filed 2012-02-21 | |||||
| 2010-09-30 | -$1.51M 10-Q · filed 2011-11-14 | -$2.84M 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | -$1.33M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |